Código QR

Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study

Abstract Background The National Comprehensive Cancer Network (NCCN) guideline recommends consideration of weekly cisplatin as an alternative option for patients with head and neck cancer undergoing definitive chemoradiation. However, in a recent phase III trial (ConCERT), 20% of patients treated wi...

Descrición completa

Gardado en:
Principais autores: Jas Virk, Jasmin Gill, Fatemeh Fekrmandi, Austin Iovoli, Mark Farrugia, Ayham Al-Afif, Kimberly Wooten, Vishal Gupta, Ryan McSpadden, Moni A. Kuriakose, Michael R. Markiewicz, Wesley L. Hicks, Sung Jun Ma, Anurag K. Singh
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2024-07-01
Series:BMC Cancer
Assuntos:
Adherence
Compliance
Concurrent chemotherapy
ChemoRT
Head and neck cancer
Weekly cisplatin
Acceso en liña:https://doi.org/10.1186/s12885-024-12615-w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares